OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2021
(5)
2023
(3)
2022
(3)
2025
(2)
2020
(2)
2014
(2)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Limitations of Conventional Magnetic Resonance Imaging as a Predictor of Death or Disability Following Neonatal Hypoxic-Ischemic Encephalopathy in the Late Hypothermia Trial.
Not available
S-EPMC7914162
|
biostudies-literature
Cite
Behavior Profiles at 2 Years for Children Born Extremely Preterm with Bronchopulmonary Dysplasia.
Not available
S-EPMC7096270
|
biostudies-literature
Cite
Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial.
Not available
S-EPMC8349854
|
biostudies-literature
Cite
Global Retinoblastoma Presentation and Analysis by National Income Level.
Not available
S-EPMC7047856
|
biostudies-literature
Cite
Factors associated with D-dimer levels in HIV-infected individuals.
Not available
S-EPMC3953205
|
biostudies-literature
Cite
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077
|
biostudies-literature
Cite
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort.
Not available
S-EPMC12464792
|
biostudies-literature
Cite
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets